No Evidence that
Journal
Disease markers
ISSN: 1875-8630
Titre abrégé: Dis Markers
Pays: United States
ID NLM: 8604127
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
05
2022
revised:
03
07
2022
accepted:
21
07
2022
entrez:
2
9
2022
pubmed:
3
9
2022
medline:
8
9
2022
Statut:
epublish
Résumé
Gemtuzumab ozogamicin (GO) is a conjugate of a monoclonal antibody and calicheamicin, which has been reapproved for the treatment of acute myeloid leukemia (AML). AML patients with the
Identifiants
pubmed: 36051360
doi: 10.1155/2022/3132941
pmc: PMC9427256
doi:
Substances chimiques
Aminoglycosides
0
Antibodies, Monoclonal, Humanized
0
CD33 protein, human
0
Sialic Acid Binding Ig-like Lectin 3
0
Gemtuzumab
93NS566KF7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3132941Informations de copyright
Copyright © 2022 Tamara Castaño-Bonilla et al.
Déclaration de conflit d'intérêts
T.C.B. is a PhD candidate at Universidad Autónoma de Madrid (UAM). No other conflicts of interest were declared.
Références
Blood. 2018 Jan 25;131(4):468-471
pubmed: 29229596
J Clin Oncol. 2014 Sep 20;32(27):3021-32
pubmed: 25092781
Haematologica. 2019 Jan;104(1):113-119
pubmed: 30076173
Blood. 2013 Jun 13;121(24):4854-60
pubmed: 23591789
Future Oncol. 2018 Dec;14(30):3199-3213
pubmed: 30039981
Leukemia. 2017 Sep;31(9):1855-1868
pubmed: 28607471
Biomed Pharmacother. 2018 Jan;97:225-232
pubmed: 29091870
Sci Rep. 2021 Oct 20;11(1):20745
pubmed: 34671057
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Lancet. 2012 Apr 21;379(9825):1508-16
pubmed: 22482940
Am J Hematol. 2020 Sep;95(9):E225-E228
pubmed: 32356320
Lancet Oncol. 2014 Aug;15(9):986-96
pubmed: 25008258
Minerva Med. 2020 Oct;111(5):395-410
pubmed: 32955828
Blood. 2010 Jan 21;115(3):453-74
pubmed: 19880497
Front Biosci (Landmark Ed). 2013 Jun 01;18(4):1311-34
pubmed: 23747885
J Clin Oncol. 2011 Feb 1;29(4):369-77
pubmed: 21172891
Expert Rev Hematol. 2016 Jan;9(1):1-3
pubmed: 26514194
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Clin Cancer Res. 2013 Mar 15;19(6):1620-7
pubmed: 23444229
Haematologica. 2021 Nov 01;106(11):2986-2989
pubmed: 34047179
Haematologica. 2019 Feb;104(2):e59-e62
pubmed: 30115657